Piotr Witold Stępień
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Piotr Witold Stępień has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Tomasz Żarnowski
Department of Diagnostic and Microsurgery of Glaucoma, Medical University of Lublin, Chmielna 1 Street, 20-079 Lublin, Poland
4 shared publications - Natalia Osial
Faculty of Medicine, Medical University of Lublin, Aleje Racławickie 1, 20-059 Lublin, Poland
3 shared publications - Adrianna Gorecka
Medical University of Lublin
2 shared publications - Dominika Wróbel-Dudzińska
Department of Diagnostics and Microsurgery of Glaucoma, Medical University of Lublin, Lublin, Poland
2 shared publications - Agnieszka Kaczyńska
Medical University of Lublin
1 shared publication - Agnieszka Wilkos-Kuc
Department of Diagnostics and Microsurgery of Glaucoma, Medical University, Chmielna 1, 20-079 Lublin, Poland
1 shared publication
Latest Publications
- Open Access
- 17 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11097
Blood Derivatives in the Therapy of Ocular Surface Diseases
The ocular surface is a structure crucial to maintaining eye health and proper vision. Unfortunately, ocular surface diseases functioning as chronic epithelial defects, inflammation, impaired healing, require immediate regenerative repair treatment that can restore tissue integrity and function. Conventional therapies, such as artificial tears and topical anti-inflammatory agents, principally provide symptomatic relief without addressing the underlying biological deficits, thus leading to incomplete or delayed recovery. Therefore, blood derivatives have emerged as a promising bioactive therapy that not only lubricates but also actively promotes regeneration through the delivery of cytokines, growth factors, and vitamins naturally present in blood. Due to their properties mimicking the components of natural tears, autologous origin, biocompatibility and capacity to enhance tissue repair, they have emerged as a cornerstone in regenerative medicine. Therefore, the purpose of this review was to compare the evolution, positive aspects, and drawbacks, in order to demonstrate the molecular mechanism of action and the therapeutic efficacy of different blood derivates at treating ocular surface disease. Over time, these biologic preparations have evolved from the use of simple traditional serum-based derivatives to more advanced platelet-rich products, underscoring the evolving understanding of platelet-driven molecular and cellular mechanisms in tissue regeneration. Despite their widespread use, we would like to highlight the current limitations related to the lack of standardized preparation protocols, variability in composition, and evidence-based integration into clinical practice. Finally, this review highlights contemporary research trends and depicts future directions advancing the field. Key priorities include the establishment of standardized, reproducible preparation protocols; the development of next-generation platelet-derived concentrates and biomaterials; and the integration of multi-omics technologies to achieve comprehensive profiling of their biological and therapeutic activity. Moving toward methodological standardization and the execution of well-designed, high-quality comparative clinical trials will be essential to reinforce the scientific foundation, enhance translational potential, and ensure the clinical reliability of blood-derived therapies in modern regenerative medicine.
- 17 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11097
Open AccessBlood Derivatives in the Therapy of Ocular Surface Diseases
The ocular surface is a structure crucial to maintaining eye health and proper vision. Unfortunately, ocular surface diseases functioning as chronic epithelial defects, inflammation, impaired healing, require immediate regenerative repair treatment that can restore tissue integrity and function. Conventional therapies, such as artificial tears and topical anti-inflammatory agents, principally provide symptomatic relief without addressing the underlying biological deficits, thus leading to incomplete or delayed recovery. Therefore, blood derivatives have emerged as a promising bioactive therapy that not only lubricates but also actively promotes regeneration through the delivery of cytokines, growth factors, and vitamins naturally present in blood. Due to their properties mimicking the components of natural tears, autologous origin, biocompatibility and capacity to enhance tissue repair, they have emerged as a cornerstone in regenerative medicine. Therefore, the purpose of this review was to compare the evolution, positive aspects, and drawbacks, in order to demonstrate the molecular mechanism of action and the therapeutic efficacy of different blood derivates at treating ocular surface disease. Over time, these biologic preparations have evolved from the use of simple traditional serum-based derivatives to more advanced platelet-rich products, underscoring the evolving understanding of platelet-driven molecular and cellular mechanisms in tissue regeneration. Despite their widespread use, we would like to highlight the current limitations related to the lack of standardized preparation protocols, variability in composition, and evidence-based integration into clinical practice. Finally, this review highlights contemporary research trends and depicts future directions advancing the field. Key priorities include the establishment of standardized, reproducible preparation protocols; the development of next-generation platelet-derived concentrates and biomaterials; and the integration of multi-omics technologies to achieve comprehensive profiling of their biological and therapeutic activity. Moving toward methodological standardization and the execution of well-designed, high-quality comparative clinical trials will be essential to reinforce the scientific foundation, enhance translational potential, and ensure the clinical reliability of blood-derived therapies in modern regenerative medicine.
- Open Access
- 29 October 2025
- Published by Termedia Sp. z.o.o. in Ophthalmology
- Vol. 28 (2) , 40-45
Capsular Glaucoma and Other Ophthalmic Complications of Pseudoexfoliation Syndrome
Pseudoexfoliation syndrome is an age-related disorder of the extracellular matrix, characterized by the deposition of pathological fibrillar material in the structures of the anterior segment of the eye and in extraocular tissues. The accumulation of pseudoexfoliative material leads to damage and impaired function of tissues such as the lens zonules, the iris, or the drainage angle. Pseudoexfoliation syndrome is a disease entity with a multifactorial pathogenesis, involving both genetic and environmental factors, among which LOXL1 gene polymorphisms, exposure to UV radiation, and oxidative stress play a particularly significant role. Pseudoexfoliation syndrome is the most common cause of secondary open-angle glaucoma, which is characterized by a more severe course and a poorer prognosis compared to primary open-angle glaucoma. Secondary open-angle glaucoma is associated with higher intraocular pressure values and its greater diurnal fluctuations. The treatment of secondary open-angle glaucoma involves the same methods as those used for primary open-angle glaucoma; however, the specific features of glaucoma in this patient group must be taken into account. Pseudoexfoliation syndrome also predisposes to cataract formation and intra- and postoperative complications, such as poor pupillary dilation, corneal decompensation, or lens dislocation, as well as systemic diseases. Due to its prevalence and clinical significance, Pseudoexfoliation syndrome represents a major diagnostic and therapeutic challenge in contemporary ophthalmology.
- 29 October 2025
- Published by Termedia Sp. z.o.o. in Ophthalmology
- Vol. 28 (2) , 40-45
Open AccessCapsular Glaucoma and Other Ophthalmic Complications of Pseudoexfoliation Syndrome
Pseudoexfoliation syndrome is an age-related disorder of the extracellular matrix, characterized by the deposition of pathological fibrillar material in the structures of the anterior segment of the eye and in extraocular tissues. The accumulation of pseudoexfoliative material leads to damage and impaired function of tissues such as the lens zonules, the iris, or the drainage angle. Pseudoexfoliation syndrome is a disease entity with a multifactorial pathogenesis, involving both genetic and environmental factors, among which LOXL1 gene polymorphisms, exposure to UV radiation, and oxidative stress play a particularly significant role. Pseudoexfoliation syndrome is the most common cause of secondary open-angle glaucoma, which is characterized by a more severe course and a poorer prognosis compared to primary open-angle glaucoma. Secondary open-angle glaucoma is associated with higher intraocular pressure values and its greater diurnal fluctuations. The treatment of secondary open-angle glaucoma involves the same methods as those used for primary open-angle glaucoma; however, the specific features of glaucoma in this patient group must be taken into account. Pseudoexfoliation syndrome also predisposes to cataract formation and intra- and postoperative complications, such as poor pupillary dilation, corneal decompensation, or lens dislocation, as well as systemic diseases. Due to its prevalence and clinical significance, Pseudoexfoliation syndrome represents a major diagnostic and therapeutic challenge in contemporary ophthalmology.
- Open Access
- 29 October 2025
- Published by Termedia Sp. z.o.o. in Ophthalmology
- Vol. 28 (2) , 36-40
Neovascular glaucoma
Neovascular glaucoma is an aggressive form of secondary angle-closure glaucoma that can potentially lead to blindness. It is characterized by neovascularization of the iris and the drainage angle. The proliferation of fibrovascular tissue within the drainage angle leads to the formation of peripheral anterior synechiae and an increase in intraocular pressure. Neovascular glaucoma develops as a consequence of ischemia and hypoxia in the posterior segment of the eye. The ischemic retina produces pro-angiogenic factors. The most important factor in the process of neovascularization is vascular endothelial growth factor. The most common underlying causes of neovascular glaucoma are diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome. The course of neovascular glaucoma can be divided into four stages: pre-rubeosis stage, iris rubeosis, secondary open-angle glaucoma, and secondary angle-closure glaucoma. Management of neovascular glaucoma focuses on treating retinal ischemia, controlling neovascularization, and reducing intraocular pressure. The aim of treatment is to prevent vision loss through panretinal photocoagulation, intravitreal and intracameral anti-VEGF injections, and glaucoma treatment, including pharmacological therapy and surgical procedures. It is essential to address the underlying disease.
- 29 October 2025
- Published by Termedia Sp. z.o.o. in Ophthalmology
- Vol. 28 (2) , 36-40
Open AccessNeovascular glaucoma
Neovascular glaucoma is an aggressive form of secondary angle-closure glaucoma that can potentially lead to blindness. It is characterized by neovascularization of the iris and the drainage angle. The proliferation of fibrovascular tissue within the drainage angle leads to the formation of peripheral anterior synechiae and an increase in intraocular pressure. Neovascular glaucoma develops as a consequence of ischemia and hypoxia in the posterior segment of the eye. The ischemic retina produces pro-angiogenic factors. The most important factor in the process of neovascularization is vascular endothelial growth factor. The most common underlying causes of neovascular glaucoma are diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome. The course of neovascular glaucoma can be divided into four stages: pre-rubeosis stage, iris rubeosis, secondary open-angle glaucoma, and secondary angle-closure glaucoma. Management of neovascular glaucoma focuses on treating retinal ischemia, controlling neovascularization, and reducing intraocular pressure. The aim of treatment is to prevent vision loss through panretinal photocoagulation, intravitreal and intracameral anti-VEGF injections, and glaucoma treatment, including pharmacological therapy and surgical procedures. It is essential to address the underlying disease.
- Open Access
- 13 December 2024
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 25, 248-254
Gender dysphoria and incongruence - neurophysiological diversity and genetic factors
Introduction: Transgender people may experience gender dysphoria, which is defined as the distress and impairment associated with a person's perception of a marked incongruity between their gender identification and their sex assigned at birth. The aim of the study is to understand the neurophysiological diversity of people with and without dysphoria, as well as to assess the genetic, endocrine and biological basis of the development of dysphoria. Material and methods: A review of the available literature was performed by searching the Google Scholar and PubMed databases using the keywords: dysphoria, gender incongruity, neurophysiology, neurophysiological diversity and dysphoria, gender dysphoria and genetics. This publication is based on a literature review covering the years 2015 - 2023. Works published before 2015 were excluded from the analysis. The SANRA scale was used to maintain the high quality of the narrative review. Results: Gender dysphoria has a polygenic basis, involving interactions between various genes and their polymorphisms. Endocrine factors are also important, so the most complete picture of the neurophysiological basis of gender dysphoria can be obtained by adding brain imaging tests and measurements of sex hormone concentrations to genetic tests. Conclusions: Determining what biological factors contribute to gender dysphoria may have a positive impact on the mental health of transgender people. Moreover, this knowledge can be used to improve the quality of diagnosis and treatment of these people. Therefore, there is a clinical need to conduct further research in this field.
- 13 December 2024
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 25, 248-254
Open AccessGender dysphoria and incongruence - neurophysiological diversity and genetic factors
Introduction: Transgender people may experience gender dysphoria, which is defined as the distress and impairment associated with a person's perception of a marked incongruity between their gender identification and their sex assigned at birth. The aim of the study is to understand the neurophysiological diversity of people with and without dysphoria, as well as to assess the genetic, endocrine and biological basis of the development of dysphoria. Material and methods: A review of the available literature was performed by searching the Google Scholar and PubMed databases using the keywords: dysphoria, gender incongruity, neurophysiology, neurophysiological diversity and dysphoria, gender dysphoria and genetics. This publication is based on a literature review covering the years 2015 - 2023. Works published before 2015 were excluded from the analysis. The SANRA scale was used to maintain the high quality of the narrative review. Results: Gender dysphoria has a polygenic basis, involving interactions between various genes and their polymorphisms. Endocrine factors are also important, so the most complete picture of the neurophysiological basis of gender dysphoria can be obtained by adding brain imaging tests and measurements of sex hormone concentrations to genetic tests. Conclusions: Determining what biological factors contribute to gender dysphoria may have a positive impact on the mental health of transgender people. Moreover, this knowledge can be used to improve the quality of diagnosis and treatment of these people. Therefore, there is a clinical need to conduct further research in this field.
- Open Access
- 11 January 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (2) , 1313
Prevalence of Dry Eye Symptoms and Associated Risk Factors among University Students in Poland
Aim: The aim of the study was to demonstrate the prevalence and risk factors of dry eye symptoms (DES) among university students in Poland. Material and methods: A cross-sectional study survey was conducted among 312 Polish university students. The questionnaire consisted of the Ocular Surface Disease Index (OSDI), the 5-Item Dry Eye Questionnaire (DEQ-5) and questions regarding medical history and risk factors. Results: According to the OSDI, more than half of respondents (57.1%) have symptoms of ocular surface disease. Time spent using electronic devices is correlated with scores gathered in both OSDI and DEQ-5 (p < 0.001). There is a statistically significant dependence between psychotropics (p = 0.002), glucocorticosteroids usage (p = 0.026), the presence of depression (p < 0.001), diabetes (p = 0.01) or allergy (p = 0.008) and dry eye symptoms proved in both questionnaires. Respondents with refractive errors and those living in metropolitan areas have a statistically higher symptom intensity(p < 0.022). Stress felt by students is associated with higher DES risk. No correlation between DES and smoking habits was observed. The history of SARS-CoV-2 infection was associated with the severity of DES (p = 0.036). Conclusion: Pathogenesis of DES is multifactorial and its severity depends on several factors, both genetic and environmental. Its prevalence among the young population is underestimated. Determining risk factors will enable the implementation of appropriate prophylaxis and early diagnosis.
- 11 January 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (2) , 1313
Open AccessPrevalence of Dry Eye Symptoms and Associated Risk Factors among University Students in Poland
Aim: The aim of the study was to demonstrate the prevalence and risk factors of dry eye symptoms (DES) among university students in Poland. Material and methods: A cross-sectional study survey was conducted among 312 Polish university students. The questionnaire consisted of the Ocular Surface Disease Index (OSDI), the 5-Item Dry Eye Questionnaire (DEQ-5) and questions regarding medical history and risk factors. Results: According to the OSDI, more than half of respondents (57.1%) have symptoms of ocular surface disease. Time spent using electronic devices is correlated with scores gathered in both OSDI and DEQ-5 (p < 0.001). There is a statistically significant dependence between psychotropics (p = 0.002), glucocorticosteroids usage (p = 0.026), the presence of depression (p < 0.001), diabetes (p = 0.01) or allergy (p = 0.008) and dry eye symptoms proved in both questionnaires. Respondents with refractive errors and those living in metropolitan areas have a statistically higher symptom intensity(p < 0.022). Stress felt by students is associated with higher DES risk. No correlation between DES and smoking habits was observed. The history of SARS-CoV-2 infection was associated with the severity of DES (p = 0.036). Conclusion: Pathogenesis of DES is multifactorial and its severity depends on several factors, both genetic and environmental. Its prevalence among the young population is underestimated. Determining risk factors will enable the implementation of appropriate prophylaxis and early diagnosis.
- Open Access
- 14 July 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7761
The Role of Dysregulated miRNAs in the Pathogenesis, Diagnosis and Treatment of Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is an eye disease causing damage to the macular region of the retina where most of the photoreceptors responsible for central visual acuity are located. MicroRNAs (miRNAs) are small single-stranded non-coding RNA molecules that negatively regulate genes by silent post-transcriptional gene expressions. Previous studies have shown that changes in specific miRNAs are involved in the pathogenesis of eye diseases, including AMD. Altered expressions of miRNAs are related to disturbances of regulating oxidative stress, inflammation, angiogenesis, apoptosis and phagocytosis, which are known factors in the pathogenesis of AMD. Moreover, dysregulation of miRNA is involved in drusen formation. Thus, miRNAs may be used as potential molecular biomarkers for the disease and, furthermore, tailoring therapeutics to particular disturbances in miRNAs may, in the future, offer hope to prevent irreversible vision loss. In this review, we clarify the current state of knowledge about the influence of miRNA on the pathogenesis, diagnosis and treatment of AMD. Our study material consisted of publications, which were found in PubMed, Google Scholar and Embase databases using “Age-related macular degeneration”, “miRNA”, “AMD biomarkers”, “miRNA therapeutics” and “AMD pathogenesis” as keywords. Paper search was limited to articles published from 2011 to date. In the section “Retinal, circulating and vitreous body miRNAs found in human studies”, we limited the search to studies with patients published in 2016–2021.
- 14 July 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7761
Open AccessThe Role of Dysregulated miRNAs in the Pathogenesis, Diagnosis and Treatment of Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is an eye disease causing damage to the macular region of the retina where most of the photoreceptors responsible for central visual acuity are located. MicroRNAs (miRNAs) are small single-stranded non-coding RNA molecules that negatively regulate genes by silent post-transcriptional gene expressions. Previous studies have shown that changes in specific miRNAs are involved in the pathogenesis of eye diseases, including AMD. Altered expressions of miRNAs are related to disturbances of regulating oxidative stress, inflammation, angiogenesis, apoptosis and phagocytosis, which are known factors in the pathogenesis of AMD. Moreover, dysregulation of miRNA is involved in drusen formation. Thus, miRNAs may be used as potential molecular biomarkers for the disease and, furthermore, tailoring therapeutics to particular disturbances in miRNAs may, in the future, offer hope to prevent irreversible vision loss. In this review, we clarify the current state of knowledge about the influence of miRNA on the pathogenesis, diagnosis and treatment of AMD. Our study material consisted of publications, which were found in PubMed, Google Scholar and Embase databases using “Age-related macular degeneration”, “miRNA”, “AMD biomarkers”, “miRNA therapeutics” and “AMD pathogenesis” as keywords. Paper search was limited to articles published from 2011 to date. In the section “Retinal, circulating and vitreous body miRNAs found in human studies”, we limited the search to studies with patients published in 2016–2021.
- Open Access
- 10 May 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (7) , 30-39
Glaucoma - the significant challenge for the healthcare system in Poland
Introduction Glaucoma is a group of optic neuropathies characterized by progressive degeneration of retinal ganglion cells (RGCs) and visual field loss. Glaucoma is the leading cause of irreversible blindness in the world. The World Health Organization classifies it as a social and civilization disease and emphasizes the need to improve ophthalmic care systems in order to meet the constantly growing challenge for public health, which is glaucoma. The aim of this article is to identify the main problems that affect the health care system of patients with glaucoma in Poland. Review methods The review of literature on glaucoma was performed using the PubMed and Google Scholar databases. The latest available epidemiological data and the current legal acts concerning the health care system of patients with glaucoma in Poland were also analyzed. Abbreviated description of the state of knowledge The incidence of glaucoma in Poland is constantly increasing, due to the aging of the population. The insidious course of the disease, low public awareness and difficulties in access effective ophthalmic services mean that the disease is diagnosed too late, when significant damage to the optic nerve has already occurred. In addition, the poor mental health of patients, treatment difficulties related to the frequent comorbidity of general diseases and the use of other drug therapies, complicate the course of glaucoma and make it difficult to inhibit its progression. Summary Glaucoma is a significant challenge for public health and the healthcare system in Poland. Therefore, it is very important to take systemic measures as soon as possible that contribute to improve public awareness of eye diseases, increase the availability of ophthalmic care, early detection and appropriate monitoring of the course of glaucoma.
- 10 May 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (7) , 30-39
Open AccessGlaucoma - the significant challenge for the healthcare system in Poland
Introduction Glaucoma is a group of optic neuropathies characterized by progressive degeneration of retinal ganglion cells (RGCs) and visual field loss. Glaucoma is the leading cause of irreversible blindness in the world. The World Health Organization classifies it as a social and civilization disease and emphasizes the need to improve ophthalmic care systems in order to meet the constantly growing challenge for public health, which is glaucoma. The aim of this article is to identify the main problems that affect the health care system of patients with glaucoma in Poland. Review methods The review of literature on glaucoma was performed using the PubMed and Google Scholar databases. The latest available epidemiological data and the current legal acts concerning the health care system of patients with glaucoma in Poland were also analyzed. Abbreviated description of the state of knowledge The incidence of glaucoma in Poland is constantly increasing, due to the aging of the population. The insidious course of the disease, low public awareness and difficulties in access effective ophthalmic services mean that the disease is diagnosed too late, when significant damage to the optic nerve has already occurred. In addition, the poor mental health of patients, treatment difficulties related to the frequent comorbidity of general diseases and the use of other drug therapies, complicate the course of glaucoma and make it difficult to inhibit its progression. Summary Glaucoma is a significant challenge for public health and the healthcare system in Poland. Therefore, it is very important to take systemic measures as soon as possible that contribute to improve public awareness of eye diseases, increase the availability of ophthalmic care, early detection and appropriate monitoring of the course of glaucoma.